297 related articles for article (PubMed ID: 236402)
1. Immunotherapy of malignancy in humans. Current status.
Holmes EC; Eilber FR; Morton DL
JAMA; 1975 Jun; 232(10):1052-5. PubMed ID: 236402
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of patients with cancer.
Smith GV; Morse PA; Deraps GD; Raju S; Hardy JD
Surgery; 1973 Jul; 74(1):59-68. PubMed ID: 4715883
[No Abstract] [Full Text] [Related]
3. [Development in the immunotherapy of malignant melanoma].
Tritsch H
Hautarzt; 1976 Jan; 27(1):1-7. PubMed ID: 767300
[TBL] [Abstract][Full Text] [Related]
4. The role of immunology in the diagnosis and treatment of cancer.
Humphrey LJ; Pierce GE
Prog Clin Cancer; 1975; 6():15-36. PubMed ID: 53858
[No Abstract] [Full Text] [Related]
5. Approaches to immunotherapy.
McKhann CF; Gunnarsson A
Cancer; 1974 Oct; 34(4 Suppl):suppl:1521-31. PubMed ID: 4608719
[No Abstract] [Full Text] [Related]
6. Intralesional treatment of recurrent metastatic cutaneous malignant melanoma: a randomized prospective study of intralesional Bacillus Calmette-Guerin versus intralesional dinitrochlorobenzene.
Cohen MH; Jessup JM; Felix EL; Weese JL; Herberman RB
Cancer; 1978 Jun; 41(6):2456-63. PubMed ID: 657108
[TBL] [Abstract][Full Text] [Related]
7. Immunology and immunotherapy of human-malignant melanoma: historic review and perspectives for the future.
Gutterman JU; Mavligit G; Reed R; Richman S; McBride CE; Hersh EM
Semin Oncol; 1975 Jun; 2(2):155-74. PubMed ID: 790574
[No Abstract] [Full Text] [Related]
8. BCG in tumor immunotherapy.
Baldwin RW; Pimm MV
Adv Cancer Res; 1978; 28():91-147. PubMed ID: 360797
[No Abstract] [Full Text] [Related]
9. BCG in cancer therapy: theoretical bases of immunotherapy.
Dodd MJ
Am J Nurs; 1979 Feb; 79(2):310-4. PubMed ID: 311587
[No Abstract] [Full Text] [Related]
10. Immunotherapy for cancer: an overview.
Proctor JW; Lewis MG; Mansell PW
Can J Surg; 1976 Jan; 19(1):12-9. PubMed ID: 1145
[TBL] [Abstract][Full Text] [Related]
11. Radiation therapy and immunotherapy: the value of immunotherapy in the control of local and regional cancer.
Cancer; 1976 Apr; 37(4 Suppl):2108-19. PubMed ID: 769945
[No Abstract] [Full Text] [Related]
12. Nonspecific immunotherapy of malignant tumors.
Milas L; Withers HR
Radiology; 1976 Jan; 118(1):211-8. PubMed ID: 1105663
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of human cancer.
Hersh EM; Gutterman JU; Mavligit GM
Adv Intern Med; 1977; 22():145-85. PubMed ID: 65906
[No Abstract] [Full Text] [Related]
14. [Problems of the immunotherapy of malignant neoplasma].
Trapeznikov NN; Iavorskiĭ VV
Klin Med (Mosk); 1975 May; 52(5):15-22. PubMed ID: 1094178
[No Abstract] [Full Text] [Related]
15. [Problems of cancer immunotherapy (author's transl)].
Gericke D
MMW Munch Med Wochenschr; 1977 Nov; 119(46):1497-1500. PubMed ID: 414081
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of cancer: current status.
Goodnight JE; Morton DL
Prog Exp Tumor Res; 1980; 25():61-88. PubMed ID: 6986637
[No Abstract] [Full Text] [Related]
17. Immunotherapy of cancer. Present status and future potential.
Morton DL
Cancer; 1972 Dec; 30(6):1647-55. PubMed ID: 4565820
[No Abstract] [Full Text] [Related]
18. [Immunotherapy of malignant melanomas].
Macher E
Haematol Blood Transfus; 1978; 21():285-91. PubMed ID: 738638
[No Abstract] [Full Text] [Related]
19. Cancer immunotherapy: an overview.
Morton DL
Semin Oncol; 1974 Dec; 1(4):297-310. PubMed ID: 4620437
[No Abstract] [Full Text] [Related]
20. A multiphase immunotherapy regimen for human melanoma: clinical and laboratory results.
Levy NL; Seigler HF; Shingleton WW
Cancer; 1974 Oct; 34(4 Suppl):suppl:1548-57. PubMed ID: 4421918
[No Abstract] [Full Text] [Related]
[Next] [New Search]
